{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:46:23Z","timestamp":1770270383141,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Aim:<\/jats:title>\n            <jats:p>This study was concerned with whether vWF (von Willebrand factor) and a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) has altered in patients with cirrhosis and extrahepatic portal hypertension (EPH). We aimed to investigate changes to vWF and ADAMTS13 in children with cirrhosis and EPH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>This study was conducted between January and October 2019 with both cirrhosis and EPH patients and with healthy volunteers. The von Willebrand factor antigen (vWF:Ag), von Willebrand Ristocetin cofactor (vWF:RCo), and ADAMTS13 antigen and activity were studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-eight children with cirrhosis, 16 children with EPH, and 20 healthy controls were included in the study. vWF:Ag and vWF:RCo levels were higher in patients with cirrhosis than in healthy controls (171.65\u00b1101.67 vs. 85.86\u00b130.58, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01 and 121.62\u00b155.83 vs. 61.52\u00b127.03, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01, respectively). vWF:Ag and vWF:RCo levels were higher in patients with EPH than in healthy controls (133.93\u00b180.13 vs. 85.86\u00b130.58, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01 and 103.18\u00b158.55 vs. 61.52\u00b127.03, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02, respectively). The ADAMTS13 antigen and activity levels were lower in patients with cirrhosis than in healthy controls (0.58\u00b10.23 vs. 0.97\u00b10.15, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01 and 49.91\u00b122.43 vs. 86.51\u00b122.07, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02, respectively). The ADAMTS13 antigen and activity levels were lower in patients with EPH than in healthy controls (0.69\u00b10.11 vs. 0.97\u00b10.15, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.03; and 68.50\u00b113.29 vs. 86.51\u00b122.07, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02, respectively). The increase in vWF and the decrease in ADAMTS13 were more pronounced in cirrhotic patients with autoimmune hepatitis (AIH) than in non-AIH patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>While levels of vWF:Ag and vWF:RCo increased in children with cirrhosis and EPH, levels of the ADAMTS13 antigen and ADAMTS13 activity decreased. These alterations were more pronounced in patients with AIH\u2013derived cirrhosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002038","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:13:36Z","timestamp":1608862416000},"page":"e951-e956","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension"],"prefix":"10.1097","volume":"43","author":[{"given":"Ali","family":"Islek","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Ilhan","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurinnisa","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Medical Biochemistry, Atat\u00fcrk University School of Medicine, Erzurum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Guven","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Karadeniz Technical University School of Medicine, Trabzon, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Sag","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Karadeniz Technical University School of Medicine, Trabzon, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","article-title":"Hemostasis and thrombosis in patients with liver disease: the ups and downs","volume":"53","author":"Lisman","year":"2010","journal-title":"J Hepatol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11739-016-1467-x","article-title":"Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study","volume":"11","author":"Lancellotti","year":"2016","journal-title":"Intern Emerg Med"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro","year":"1996","journal-title":"Hepatology"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.13898","article-title":"ADAMTS-13 and von Willebrand factor: a dynamic duo","volume":"16","author":"South","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2011.09.010","article-title":"Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis","volume":"10","author":"Raffa","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/asheducation-2011.1.170","article-title":"Bleeding and clotting disorders in pediatric liver disease","volume":"2011","author":"Wicklund","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007890-200207270-00006","article-title":"Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation","volume":"74","author":"McDiarmid","year":"2002","journal-title":"Transplantation"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2012.11.003","article-title":"Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency","volume":"58","author":"Elias","year":"2013","journal-title":"J Hepatol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMra003007","article-title":"Gastroesophageal variceal hemorrhage","volume":"345","author":"Sharara","year":"2001","journal-title":"N Engl J Med"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08880018.2017.1313919","article-title":"Characterization of the coagulation profile in children with liver disease and extrahepatic portal vein obstruction or shunt","volume":"34","author":"Beattie","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/pgmj.2007.066415","article-title":"Relevance of clotting tests in liver disease","volume":"84","author":"Thachil","year":"2008","journal-title":"Postgrad Med J"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/liv.12657","article-title":"Imbalance of von Willebrand factor and its cleaving protease ADAMTS 13 during systemic inflammation superimposed on advanced cirrhosis","volume":"35","author":"Reuken","year":"2015","journal-title":"Liver Int"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hep.26372","article-title":"An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome","volume":"58","author":"Hugenholtz","year":"2013","journal-title":"Hepatology"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb Haemost"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.dld.2015.12.003","article-title":"Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis","volume":"48","author":"Wiese","year":"2016","journal-title":"Dig Liver Dis"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cellderived ultra large vWF multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-5-14","article-title":"Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications","volume":"5","author":"Franchini","year":"2007","journal-title":"Thromb J"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:09:34Z","timestamp":1754338174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002038","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"2020-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}